Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-11-07

AUTHORS

A. Kasprzak, K. Nachtkamp, M. Kondakci, T. Schroeder, G. Kobbe, A. Kündgen, J. Kaivers, C. Rautenberg, R. Haas, N. Gattermann, N. Bonadies, U. Germing

ABSTRACT

The European Leukemia Net (ELN) guidelines for treatment of myelodysplastic syndromes (MDS) connect heterogeneous MDS subgroups with a number of therapeutic options ranging from best supportive care to allogeneic stem cell transplantation (alloSCT). However, it is currently unknown whether adherence to guideline recommendations translates into improved survival. The sizeable database of the Duesseldorf MDS Registry allowed us to address this question. We first performed a retrospective analysis including 1698 patients (cohort 1) to whom we retrospectively applied the ELN guidelines. We compared patients treated according to the guidelines with patients who deviated from it, either because they received a certain treatment though it was not recommended or because they did not receive that treatment despite being eligible. We also performed a prospective study with 381 patients (cohort 2) who were seen in our department and received guideline-based expert advice. Again, we compared the impact of subsequent guideline-adherent versus non-adherent treatment. For the majority of treatment options (best supportive care, lenalidomide, hypomethylating agents, low-dose chemotherapy, and intensive chemotherapy), we found that adherence to the ELN guidelines did not improve survival in cohort 1. The same was true when patient management was prospectively enhanced through guideline-based treatment advice given by MDS experts (cohort 2). The only exceptions were alloSCT and iron chelation (ICT). Patients receiving ICT and alloSCT as recommended fared significantly better than those who were eligible but received other treatment. Our analysis underscores the limited survival impact of most MDS therapies and suggests to pursue alloSCT in all suitable candidates.Graphical abstract More... »

PAGES

455-463

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-020-04325-7

DOI

http://dx.doi.org/10.1007/s00277-020-04325-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1132411275

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33159566


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Databases, Factual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guideline Adherence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelodysplastic Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Homologous", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kasprzak", 
        "givenName": "A.", 
        "id": "sg:person.07523237173.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07523237173.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nachtkamp", 
        "givenName": "K.", 
        "id": "sg:person.01367010764.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367010764.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kondakci", 
        "givenName": "M.", 
        "id": "sg:person.01150516001.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150516001.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schroeder", 
        "givenName": "T.", 
        "id": "sg:person.01271136615.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobbe", 
        "givenName": "G.", 
        "id": "sg:person.01164073234.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "K\u00fcndgen", 
        "givenName": "A.", 
        "id": "sg:person.01107510155.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107510155.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaivers", 
        "givenName": "J.", 
        "id": "sg:person.011353714763.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011353714763.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rautenberg", 
        "givenName": "C.", 
        "id": "sg:person.014702750321.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014702750321.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haas", 
        "givenName": "R.", 
        "id": "sg:person.01127414674.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gattermann", 
        "givenName": "N.", 
        "id": "sg:person.01273447501.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.5734.5", 
          "name": [
            "Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonadies", 
        "givenName": "N.", 
        "id": "sg:person.01240162452.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240162452.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.14778.3d", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Germing", 
        "givenName": "U.", 
        "id": "sg:person.01362464041.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12185-017-2367-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092991806", 
          "https://doi.org/10.1007/s12185-017-2367-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-010-1132-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007208944", 
          "https://doi.org/10.1007/s10549-010-1132-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41375-019-0673-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1123431312", 
          "https://doi.org/10.1038/s41375-019-0673-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-11-07", 
    "datePublishedReg": "2020-11-07", 
    "description": "The European Leukemia Net (ELN) guidelines for treatment of myelodysplastic syndromes (MDS) connect heterogeneous MDS subgroups with a number of therapeutic options ranging from best supportive care to allogeneic stem cell transplantation (alloSCT). However, it is currently unknown whether adherence to guideline recommendations translates into improved survival. The sizeable database of the Duesseldorf MDS Registry allowed us to address this question. We first performed a retrospective analysis including 1698 patients (cohort 1) to whom we retrospectively applied the ELN guidelines. We compared patients treated according to the guidelines with patients who deviated from it, either because they received a certain treatment though it was not recommended or because they did not receive that treatment despite being eligible. We also performed a prospective study with 381 patients (cohort 2) who were seen in our department and received guideline-based expert advice. Again, we compared the impact of subsequent guideline-adherent versus non-adherent treatment. For the majority of treatment options (best supportive care, lenalidomide, hypomethylating agents, low-dose chemotherapy, and intensive chemotherapy), we found that adherence to the ELN guidelines did not improve survival in cohort 1. The same was true when patient management was prospectively enhanced through guideline-based treatment advice given by MDS experts (cohort 2). The only exceptions were alloSCT and iron chelation (ICT). Patients receiving ICT and alloSCT as recommended fared significantly better than those who were eligible but received other treatment. Our analysis underscores the limited survival impact of most MDS therapies and suggests to pursue alloSCT in all suitable candidates.Graphical abstract", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-020-04325-7", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "100"
      }
    ], 
    "keywords": [
      "myelodysplastic syndrome", 
      "ELN guidelines", 
      "iron chelation", 
      "European Leukemia Net guidelines", 
      "allogeneic stem cell transplantation", 
      "Duesseldorf MDS Registry", 
      "non-adherent treatment", 
      "best supportive care", 
      "stem cell transplantation", 
      "impact of adherence", 
      "MDS Registry", 
      "supportive care", 
      "survival impact", 
      "therapeutic options", 
      "prospective study", 
      "cell transplantation", 
      "treatment options", 
      "MDS subgroup", 
      "cohort 1", 
      "retrospective analysis", 
      "patient management", 
      "patients", 
      "treatment advice", 
      "alloSCT", 
      "treatment", 
      "adherence", 
      "MDS experts", 
      "syndrome", 
      "certain treatments", 
      "survival", 
      "guidelines", 
      "expert advice", 
      "advice", 
      "transplantation", 
      "options", 
      "registry", 
      "therapy", 
      "care", 
      "subgroups", 
      "Department", 
      "suitable candidate", 
      "majority", 
      "only exception", 
      "management", 
      "impact", 
      "database", 
      "analysis", 
      "study", 
      "chelation", 
      "sizeable database", 
      "exception", 
      "candidates", 
      "number", 
      "translates", 
      "experts", 
      "questions", 
      "Abstract Analysis"
    ], 
    "name": "Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes", 
    "pagination": "455-463", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1132411275"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-020-04325-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33159566"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-020-04325-7", 
      "https://app.dimensions.ai/details/publication/pub.1132411275"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_855.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-020-04325-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-020-04325-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-020-04325-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-020-04325-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-020-04325-7'


 

This table displays all metadata directly associated to this object as RDF triples.

262 TRIPLES      21 PREDICATES      98 URIs      87 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-020-04325-7 schema:about N1ab600c1acb94f61815c80b464a67724
2 N29ec482c105340a4ac4e71883c562a89
3 N2cfce284d0794e47bf549820769cb7c5
4 N4bca702b138c4e059de5c760c03ab947
5 N4fca6b220f534de68f0a4116012430aa
6 N78ee472dfcf542e5ab4290344ad4b84b
7 N7b19c39223584b63bdf0779a5e9d5e27
8 N856b0b2d890744fba0f4d58711c45410
9 N8d8c185553a046409d4e755b5027ba2a
10 Na1eb0689d2c0421f8f22f37722f33bb5
11 Nb2f478ad45e44d40825b56a164871058
12 Nbd53003ee4e946e5a78116673c89c45f
13 Nfb22ffa32a5d425aa63b6607f13dc9a1
14 anzsrc-for:11
15 anzsrc-for:1102
16 schema:author N739047a13f8c477abd3f9b781f74a52e
17 schema:citation sg:pub.10.1007/s10549-010-1132-4
18 sg:pub.10.1007/s12185-017-2367-1
19 sg:pub.10.1038/s41375-019-0673-8
20 schema:datePublished 2020-11-07
21 schema:datePublishedReg 2020-11-07
22 schema:description The European Leukemia Net (ELN) guidelines for treatment of myelodysplastic syndromes (MDS) connect heterogeneous MDS subgroups with a number of therapeutic options ranging from best supportive care to allogeneic stem cell transplantation (alloSCT). However, it is currently unknown whether adherence to guideline recommendations translates into improved survival. The sizeable database of the Duesseldorf MDS Registry allowed us to address this question. We first performed a retrospective analysis including 1698 patients (cohort 1) to whom we retrospectively applied the ELN guidelines. We compared patients treated according to the guidelines with patients who deviated from it, either because they received a certain treatment though it was not recommended or because they did not receive that treatment despite being eligible. We also performed a prospective study with 381 patients (cohort 2) who were seen in our department and received guideline-based expert advice. Again, we compared the impact of subsequent guideline-adherent versus non-adherent treatment. For the majority of treatment options (best supportive care, lenalidomide, hypomethylating agents, low-dose chemotherapy, and intensive chemotherapy), we found that adherence to the ELN guidelines did not improve survival in cohort 1. The same was true when patient management was prospectively enhanced through guideline-based treatment advice given by MDS experts (cohort 2). The only exceptions were alloSCT and iron chelation (ICT). Patients receiving ICT and alloSCT as recommended fared significantly better than those who were eligible but received other treatment. Our analysis underscores the limited survival impact of most MDS therapies and suggests to pursue alloSCT in all suitable candidates.Graphical abstract
23 schema:genre article
24 schema:isAccessibleForFree true
25 schema:isPartOf N3e16a9adf6f148008906d7c132afce1e
26 N8fdab47c3f284ce19f55db36be0d6e7d
27 sg:journal.1358129
28 schema:keywords Abstract Analysis
29 Department
30 Duesseldorf MDS Registry
31 ELN guidelines
32 European Leukemia Net guidelines
33 MDS Registry
34 MDS experts
35 MDS subgroup
36 adherence
37 advice
38 alloSCT
39 allogeneic stem cell transplantation
40 analysis
41 best supportive care
42 candidates
43 care
44 cell transplantation
45 certain treatments
46 chelation
47 cohort 1
48 database
49 exception
50 expert advice
51 experts
52 guidelines
53 impact
54 impact of adherence
55 iron chelation
56 majority
57 management
58 myelodysplastic syndrome
59 non-adherent treatment
60 number
61 only exception
62 options
63 patient management
64 patients
65 prospective study
66 questions
67 registry
68 retrospective analysis
69 sizeable database
70 stem cell transplantation
71 study
72 subgroups
73 suitable candidate
74 supportive care
75 survival
76 survival impact
77 syndrome
78 therapeutic options
79 therapy
80 translates
81 transplantation
82 treatment
83 treatment advice
84 treatment options
85 schema:name Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes
86 schema:pagination 455-463
87 schema:productId N3c6477ed0706449c81055b370d53d929
88 N5008ef076c904cf98ba99777a7c47b8d
89 Nd7abe3df4fe2430dbe481f0dfe839e24
90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132411275
91 https://doi.org/10.1007/s00277-020-04325-7
92 schema:sdDatePublished 2022-08-04T17:09
93 schema:sdLicense https://scigraph.springernature.com/explorer/license/
94 schema:sdPublisher Nac079cdd3f3b43c499048944dab2cad4
95 schema:url https://doi.org/10.1007/s00277-020-04325-7
96 sgo:license sg:explorer/license/
97 sgo:sdDataset articles
98 rdf:type schema:ScholarlyArticle
99 N064a7e730d4f4dc289ccf44d6c2cdfbb rdf:first sg:person.01107510155.40
100 rdf:rest N5a76a36cc5444270b2e09d3adc2441b5
101 N0fe1eb35a65341a68c869857f71ba0e3 rdf:first sg:person.014702750321.08
102 rdf:rest N7c49bd33219c4e4781c13e6bb7da9ccc
103 N1ab600c1acb94f61815c80b464a67724 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Antineoplastic Combined Chemotherapy Protocols
105 rdf:type schema:DefinedTerm
106 N1cc21c5a982d49a39ef4e1a56f482bb7 rdf:first sg:person.01240162452.49
107 rdf:rest N971bba1f8d0c431ca678d66c334112c9
108 N29ec482c105340a4ac4e71883c562a89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Male
110 rdf:type schema:DefinedTerm
111 N2cfce284d0794e47bf549820769cb7c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Survival Rate
113 rdf:type schema:DefinedTerm
114 N3c6477ed0706449c81055b370d53d929 schema:name pubmed_id
115 schema:value 33159566
116 rdf:type schema:PropertyValue
117 N3e16a9adf6f148008906d7c132afce1e schema:volumeNumber 100
118 rdf:type schema:PublicationVolume
119 N411dc0f4cb334f3f8fd9915e8889257f rdf:first sg:person.01273447501.34
120 rdf:rest N1cc21c5a982d49a39ef4e1a56f482bb7
121 N4bca702b138c4e059de5c760c03ab947 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Disease-Free Survival
123 rdf:type schema:DefinedTerm
124 N4fca6b220f534de68f0a4116012430aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Hematopoietic Stem Cell Transplantation
126 rdf:type schema:DefinedTerm
127 N5008ef076c904cf98ba99777a7c47b8d schema:name dimensions_id
128 schema:value pub.1132411275
129 rdf:type schema:PropertyValue
130 N5a76a36cc5444270b2e09d3adc2441b5 rdf:first sg:person.011353714763.51
131 rdf:rest N0fe1eb35a65341a68c869857f71ba0e3
132 N7038b51d04214c369f20c81ef2fa5cd3 rdf:first sg:person.01367010764.53
133 rdf:rest N823fae5516ff48abbfdabbe0df485394
134 N739047a13f8c477abd3f9b781f74a52e rdf:first sg:person.07523237173.03
135 rdf:rest N7038b51d04214c369f20c81ef2fa5cd3
136 N78ee472dfcf542e5ab4290344ad4b84b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Humans
138 rdf:type schema:DefinedTerm
139 N7b19c39223584b63bdf0779a5e9d5e27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Prospective Studies
141 rdf:type schema:DefinedTerm
142 N7c49bd33219c4e4781c13e6bb7da9ccc rdf:first sg:person.01127414674.14
143 rdf:rest N411dc0f4cb334f3f8fd9915e8889257f
144 N823fae5516ff48abbfdabbe0df485394 rdf:first sg:person.01150516001.45
145 rdf:rest Na5525be475ff45f58e7cb45d6c96c00c
146 N856b0b2d890744fba0f4d58711c45410 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Retrospective Studies
148 rdf:type schema:DefinedTerm
149 N8d8c185553a046409d4e755b5027ba2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Myelodysplastic Syndromes
151 rdf:type schema:DefinedTerm
152 N8fdab47c3f284ce19f55db36be0d6e7d schema:issueNumber 2
153 rdf:type schema:PublicationIssue
154 N971bba1f8d0c431ca678d66c334112c9 rdf:first sg:person.01362464041.20
155 rdf:rest rdf:nil
156 Na1eb0689d2c0421f8f22f37722f33bb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Transplantation, Homologous
158 rdf:type schema:DefinedTerm
159 Na5525be475ff45f58e7cb45d6c96c00c rdf:first sg:person.01271136615.68
160 rdf:rest Nf11f47e1acec41f58952accf40475cd0
161 Nac079cdd3f3b43c499048944dab2cad4 schema:name Springer Nature - SN SciGraph project
162 rdf:type schema:Organization
163 Nb2f478ad45e44d40825b56a164871058 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Databases, Factual
165 rdf:type schema:DefinedTerm
166 Nbd53003ee4e946e5a78116673c89c45f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Guideline Adherence
168 rdf:type schema:DefinedTerm
169 Nd7abe3df4fe2430dbe481f0dfe839e24 schema:name doi
170 schema:value 10.1007/s00277-020-04325-7
171 rdf:type schema:PropertyValue
172 Nf11f47e1acec41f58952accf40475cd0 rdf:first sg:person.01164073234.53
173 rdf:rest N064a7e730d4f4dc289ccf44d6c2cdfbb
174 Nfb22ffa32a5d425aa63b6607f13dc9a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Female
176 rdf:type schema:DefinedTerm
177 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
178 schema:name Medical and Health Sciences
179 rdf:type schema:DefinedTerm
180 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
181 schema:name Cardiorespiratory Medicine and Haematology
182 rdf:type schema:DefinedTerm
183 sg:journal.1358129 schema:issn 0939-5555
184 1432-0584
185 schema:name Annals of Hematology
186 schema:publisher Springer Nature
187 rdf:type schema:Periodical
188 sg:person.01107510155.40 schema:affiliation grid-institutes:grid.14778.3d
189 schema:familyName Kündgen
190 schema:givenName A.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107510155.40
192 rdf:type schema:Person
193 sg:person.01127414674.14 schema:affiliation grid-institutes:grid.14778.3d
194 schema:familyName Haas
195 schema:givenName R.
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14
197 rdf:type schema:Person
198 sg:person.011353714763.51 schema:affiliation grid-institutes:grid.14778.3d
199 schema:familyName Kaivers
200 schema:givenName J.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011353714763.51
202 rdf:type schema:Person
203 sg:person.01150516001.45 schema:affiliation grid-institutes:grid.14778.3d
204 schema:familyName Kondakci
205 schema:givenName M.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150516001.45
207 rdf:type schema:Person
208 sg:person.01164073234.53 schema:affiliation grid-institutes:grid.14778.3d
209 schema:familyName Kobbe
210 schema:givenName G.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53
212 rdf:type schema:Person
213 sg:person.01240162452.49 schema:affiliation grid-institutes:grid.5734.5
214 schema:familyName Bonadies
215 schema:givenName N.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240162452.49
217 rdf:type schema:Person
218 sg:person.01271136615.68 schema:affiliation grid-institutes:grid.14778.3d
219 schema:familyName Schroeder
220 schema:givenName T.
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68
222 rdf:type schema:Person
223 sg:person.01273447501.34 schema:affiliation grid-institutes:grid.14778.3d
224 schema:familyName Gattermann
225 schema:givenName N.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34
227 rdf:type schema:Person
228 sg:person.01362464041.20 schema:affiliation grid-institutes:grid.14778.3d
229 schema:familyName Germing
230 schema:givenName U.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20
232 rdf:type schema:Person
233 sg:person.01367010764.53 schema:affiliation grid-institutes:grid.14778.3d
234 schema:familyName Nachtkamp
235 schema:givenName K.
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367010764.53
237 rdf:type schema:Person
238 sg:person.014702750321.08 schema:affiliation grid-institutes:grid.14778.3d
239 schema:familyName Rautenberg
240 schema:givenName C.
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014702750321.08
242 rdf:type schema:Person
243 sg:person.07523237173.03 schema:affiliation grid-institutes:grid.14778.3d
244 schema:familyName Kasprzak
245 schema:givenName A.
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07523237173.03
247 rdf:type schema:Person
248 sg:pub.10.1007/s10549-010-1132-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007208944
249 https://doi.org/10.1007/s10549-010-1132-4
250 rdf:type schema:CreativeWork
251 sg:pub.10.1007/s12185-017-2367-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092991806
252 https://doi.org/10.1007/s12185-017-2367-1
253 rdf:type schema:CreativeWork
254 sg:pub.10.1038/s41375-019-0673-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1123431312
255 https://doi.org/10.1038/s41375-019-0673-8
256 rdf:type schema:CreativeWork
257 grid-institutes:grid.14778.3d schema:alternateName Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany
258 schema:name Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany
259 rdf:type schema:Organization
260 grid-institutes:grid.5734.5 schema:alternateName Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
261 schema:name Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
262 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...